Characterization of a novel deletion causing (δβ) 0-thalassemia in a Thai family

American Journal of Hematology

Volumn 82, Issue 2, 2007, Pages 155-161

  Svasti, Saovaros ^a   Paksua, Surachate ^a,b   Nuchprayoon, Issarang ^c   Winichagoon, Pranee ^a   Fucharoen, Suthat ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b KASETSART UNIVERSITY   (Thailand)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

thalassemia; Fetal hemoglobin; Gene deletion

Indexed keywords

BETA GLOBIN; DELTA GLOBIN; DNA FRAGMENT; DNA POLYMERASE; HEMOGLOBIN E; HEMOGLOBIN F;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BETA THALASSEMIA; BINDING SITE; CASE REPORT; DELTA BETA THALASSEMIA; DIAGNOSTIC ERROR; FEMALE; GENE CLUSTER; GENE DELETION; GENE LOCATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; THAILAND;

ADULT; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BETA-THALASSEMIA; DNA MUTATIONAL ANALYSIS; FAMILY; FEMALE; FETAL HEMOGLOBIN; GLOBINS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MULTIGENE FAMILY; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEQUENCE DELETION; THAILAND;

EID: 33846494974     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20781     Document Type: Article

References (24)

1. Feingold EA, Forget BG. The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the β-globin gene cluster. Blood 1989;74:2178-2186.
2. Elder JT, Forrester WC, Thompson C, et al. Translocation of an erythroid-specific hypersensitive site in deletion-type hereditary persistence of fetal hemoglobin. Mol Cell Biol 1990;10: 1382-1389.
3. Arcasoy MO, Romana M, Fabry ME, Skarpidi E, Nagel RL, Forget BG. High levels of human γ-globin gene expression in adult mice carrying a transgene of deletion-type hereditary persistence of fetal hemoglobin. Mol Cell Biol 1997;17:2076-2089.
4. Katsantoni EZ, Langeveld A, Wai AW, et al. Persistent γ-globin expression in adult transgenic mice is mediated by HPFH-2, HPFH-3, and HPFH-6 breakpoint sequences. Blood 2003;102: 3412-3419.
5. Kosteas T, Palena A, Anagnou NP. Molecular cloning of the breakpoints of the hereditary persistence of fetal hemoglobin type-6 (HPFH-6) deletion and sequence analysis of the novel juxtaposed region from the 3′ end of the β-globin gene cluster. Hum Genet 1997;100:441-445.
6. Anagnou NP, Perez-Stable C, Gelinas R, et al. Sequences located 3′ to the breakpoint of the hereditary persistence of fetal hemoglobin-3 deletion exhibit enhancer activity and can modify the developmental expression of the human fetal A γ-globin gene in transgenic mice. J Biol Chem 1995;270:10256-10263.
7. Alter BP, Goff SC, Efremov GD, Gravely ME, Huisman TH. Globin chain electrophoresis: A new approach to the determination of the Gγ/Aγ ratio in fetal haemoglobin and to studies of globin synthesis. Br J Haematol 1980;44:527-534.
8. Sutton M, Bouhassira EE, Nagel RL. Polymerase chain reaction amplification applied to the determination of β-like globin gene cluster haplotypes. Am J Hematol 1989;32:66-69.
9. Gibbons R, Higgs DR, Olivieri NF, Wood WG. Hereditary persistance of fetal haemoglobin. In: Weatherall DJ, Clegg JB, editors. The Thalassemia Syndromes. Malden, MA: Blackwell Science; 2001. pp 450-483.
10. Camaschella C, Serra A, Gottardi E. et al. A new hereditary persistence of fetal hemoglobin deletion has the breakpoint within the 3′ β-globin gene enhancer. Blood 1990;75:1000-1005.
11. Palena A, Blau A, Stamatoyannopoulos G, Anagnou NP. Eastern European (δβ) zero-thalassemia: Molecular characterization of a novel 9.1-kb deletion resulting in high levels of fetal hemoglobin in the adult. Blood 1994;83:3738-3745.
12. Ottolenghi S, Giglioni B. The deletion in a type of δ0-β0- thalassaemia begins in an inverted AluI repeat. Nature 1982;300:770-771.
13. Waye JS, Eng B, Coleman MB, Steinberg MH, Alter BP. δβ- Thalassemia in an African-American: Identification of the deletion endpoints and PCR-based diagnosis. Hemoglobin 1994;18: 389-399.
14. Huisman TH, Schroeder WA, Efremov GD, et al. The present status of the heterogeneity of fetal hemoglobin in β-thalassemia: An attempt to unify some observations in thalassemia and related conditions. Ann NY Acad Sci 1974;232:107-124.
15. Vitale M, Di Marzo R, Calzolari R, et al. Evidence for a globin promoter-specific silencer element located upstream of the human delta-globin gene. Biochem Biophys Res Commun 1994;204:413-418.
16. Tuan D, Feingold E, Newman M, Weissman SM, Forget BG. Different 3δ end points of deletions causing δβ-thalassemia and hereditary persistence of fetal hemoglobin: Implications for the control of γ-globin gene expression in man. Proc Natl Acad Sci USA 1983;80:6937-6941.
17. O'Neill D, Bornschlegel K, Flamm M, Castle M, Bank A. A DNA-binding factor in adult hematopoietic cells interacts with a pyrimidine-rich domain upstream from the human δ-globin gene. Proc Natl Acad Sci USA 1991;88:8953-8957.
18. O'Neill D, Yang J, Erdjument-Bromage H, Bornschlegel K, Tempst P, Bank A. Tissue-specific and developmental stage-specific DNA binding by a mammalian SWI/SNF complex associated with human fetal-to-adult globin gene switching. Proc Natl Acad Sci USA 1999;96:349-354.
19. Calzolari R, McMorrow T, Yannoutsos N, Langeveld A, Grosveld F. Deletion of a region that is a candidate for the difference between the deletion forms of hereditary persistence of fetal hemoglobin and δβ-thalassemia affects β- but not γ-globin gene expression. EMBO J 1999;18:949-958.
20. Gaensler KM, Zhang Z, Lin C, Yang S, Hardt K, Flebbe-Rehwaldt L. Sequences in the (A)γ-δ intergenic region are not required for stage-specific regulation of the human β-globin gene locus. Proc Natl Acad Sci USA 2003;100:3374-3379.
21. Behringer RR, Hammer RE, Brinster RL, Palmiter RD, Townes TM. Two 3′ sequences direct adult erythroid-specific expression of human β-globin genes in transgenic mice. Proc Natl Acad Sci USA 1987;84:7056-7060.
22. Antoniou M, deBoer E, Habets G, Grosveld F. The human β-globin gene contains multiple regulatory regions: Identification of one promoter and two downstream enhancers. EMBO J 1988;7:377-384.
23. Jackson CE, O'Neill D, Bank A. Nuclear factor binding sites in human β globin IVS2. J Biol Chem 1995;270:28448-28456.
24. Rubin JE, Pasceri P, Wu X, Leboulch P, Ellis J. Locus control region activity by 5′HS3 requires a functional interaction with β-globin gene regulatory elements: Expression of novel β/γ-globin hybrid transgenes. Blood 2000;95:3242-3249.